|
2026
|
Invention
|
Production of highly purified 212pb.
The present invention relates to assemblies and method for ... |
|
2025
|
Invention
|
212pb. The present invention relates to assemblies and method for obtaining a container comprisin... |
|
2024
|
Invention
|
Production of highly purified 212pb. The present invention relates to assemblies and method for o... |
|
|
Invention
|
Production of highly purified 212pb. 212Pb in high purity without the need for processing, with h... |
|
|
Invention
|
Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide.
The prese... |
|
2023
|
Invention
|
Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide. The presen... |
|
|
Invention
|
Complexes for cancer treatment and imaging.
The present invention relates to complexes comprisin... |
|
|
Invention
|
Complexes for cancer treatment and imaging. The present invention relates to complexes comprising... |
|
2020
|
Invention
|
212pb. 212Pb high purity without the need for processing, with high yields, and which safely and ... |
|
2018
|
Invention
|
Lead and thorium compounds. 227Th. These compounds, and pharmaceutical compositions comprising th... |
|
2017
|
Invention
|
212pb labeled monoclonal antibodies. The present invention relates to the generation of lead-212 ... |
|
|
Invention
|
Preparation of 212pb labeled monoclonal antibodies. The present invention relates to the generati... |
|
2016
|
Invention
|
Radiopharmaceutical solutions with advantageous properties. 224Ra based solutions for medial trea... |
|
|
Invention
|
Radiopharmaceutical solutions with advantageous properties. The present invention relates ... |
|
|
Invention
|
Radiopharmaceutical solutions with advantageous properties. The present invention relates to radi... |
|
2015
|
Invention
|
Radiopharmaceutical solutions with advantageous properties. 224Ra based solutions for medical tre... |
